ゲノミクス市場規模、シェア、動向、2030年までの世界予測

ゲノミクス市場 – 製品（試薬、キット、機器）、サービス（ゲノムプロファイリング、バイオインフォマティクス）、技術（シーケンシング、PCR、ISH、フローサイトメトリー）、研究タイプ（エピゲノミクス）、アプリケーション（創薬、診断、農業） – 2030年までの世界予測

世界のゲノミクス市場は、2025年の470.7億米ドルから2030年には850.9億米ドルに達し、2025年から2030年にかけて12.6%のCAGRで成長すると予測されています。ゲノミクス市場は、政府資金の増加、ウイルス性および遺伝性疾患の蔓延の増加、次世代シーケンシング（NGS）技術の継続的な進歩に牽引され、力強い成長を遂げています。遺伝性疾患の特定や創薬における従来の用途を超えて、ゲノミクスは農業、獣医学、法医学の分野でも注目を集めています。法医学では、NGSの採用がDNA分析に革命をもたらしました。従来のDNAフィンガープリンティング法は包括的なゲノム再構築に置き換えられ、より正確な特定が可能になっています。NGSは現場での分析も容易にし、微量または劣化したDNAサンプルから詳細な遺伝情報を抽出できるため、法医学調査の精度と範囲が向上します。

この調査レポートでは、ゲノミクス市場を{製品[タイプ（試薬、キット、消耗品、機器、バイオインフォマティクスツール）、テクノロジー（シーケンシング、PCR、遺伝子編集、フローサイトメトリー、マイクロアレイ、in situハイブリダイゼーション、その他のテクノロジー）、エンドユーザー（病院、診断ラボ、クリニック、学術研究機関、製薬会社、バイオテクノロジー企業、CRO、その他のエンドユーザー）]とサービス[タイプ（ゲノミクスプロファイリングおよびシーケンシングサービス、サンプル調製およびライブラリ調製サービス、バイオインフォマティクスサービス）およびエンドユーザー（病院、診断ラボ、クリニック、学術研究機関、製薬会社、バイオテクノロジー企業、その他のエンドユーザー）]}、アプリケーション（創薬および開発、診断、農業および動物研究、その他のアプリケーション）、研究タイプ（機能ゲノミクス、バイオマーカー発見、パスウェイ解析、エピゲノミクス、その他の研究タイプ）、地域（北米、 （ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）。本レポートは、市場の成長に影響を与える主要な要因（推進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーの徹底的な分析により、各社の事業概要、製品、ソリューション、主要戦略、協業、パートナーシップ、契約に関する洞察が得られています。ゲノミクス市場における最近の動向としては、新規製品の発売、協業、買収などが挙げられます。

本レポートは、ゲノミクス市場全体とそのサブセグメントの収益数値を最も近似値で示すことで、市場リーダー／新規参入企業を支援します。また、ステークホルダーが競争環境をより深く理解し、自社のポジショニングと適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供することを可能にします。

本レポートでは、以下の点について洞察を提供しています。

市場の成長に影響を与える主要な推進要因（ゲノミクスプロジェクトへの政府資金の増加、ウイルス性疾患および遺伝性疾患の有病率の増加、NGSプラットフォームの進歩、ゲノミクスの応用範囲の拡大）、制約要因（高い投資コスト）、機会（精密医療におけるゲノミクスの利用増加とゲノミクス技術の進歩）、課題（大量データセットの取り扱いとその分析、そしてゲノミクスの臨床的有用性）の分析。

• 製品開発／イノベーション：ゲノミクス市場における新製品／サービスに関する詳細な洞察。
• 市場開発：収益性の高い市場に関する包括的な情報。本レポートでは、様々な地域にわたる市場分析を実施しています。
• 市場の多様化：ゲノミクス市場における新製品／サービス、未開拓地域、最近の動向、投資に関する網羅的な情報。
• 競合分析：Illumina, Inc.（米国）、Thermo Fisher Scientific Inc.（米国）、F. Hoffmann-La Roche Ltd.（スイス）、Danaher Corporation（米国）、QIAGEN（ドイツ）、Agilent Technologies, Inc.（米国）、Revvity（米国）、Laboratory Corporation of America Holdings（米国）、IQVIA Inc.（米国）など。

Report Description

The global genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, exhibiting a CAGR of 12.6% from 2025 to 2030. The genomics market is experiencing strong growth, driven by increasing government funding, the rising prevalence of viral and hereditary diseases, and ongoing advancements in next-generation sequencing (NGS) technologies. Beyond traditional applications in genetic disorder identification and drug discovery, genomics is gaining traction in agriculture, veterinary science, and forensics. In forensics, the adoption of NGS has revolutionized DNA analysis. Traditional DNA fingerprinting methods are being replaced by comprehensive genomic reconstruction, enabling more precise identification. NGS also facilitates on-site analysis, allowing the extraction of detailed genetic information from trace or degraded DNA samples, thereby enhancing the accuracy and scope of forensic investigations.

“The reagents, kits, and consumables segment is projected to record the highest CAGR during the forecast period.”

Based on product type, the genomics market is segmented into reagents, kits, and consumables; instruments; and bioinformatics tools. The reagents, kits, and consumables segment accounted for the largest share of the product market. Reagents and kits are essential for nearly all genomic workflows, including DNA and RNA extraction, amplification, sequencing, and analysis. They are vital for both research and clinical applications. The demand for these products is driven by the increasing number of genomic experiments conducted in diagnostics, personalized medicine, and drug development. Each workflow requires a consistent supply of high-quality reagents and kits to ensure the accurate and reliable generation of genomic data.

Moreover, the rapid adoption of advanced technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) further increases the need for application-specific reagents and consumables. The ongoing growth in genomics sectors, such as healthcare, research, and biotechnology, enhances the revenue generated from consumables, solidifying its leading market position.

“The hospitals, diagnostic laboratories, and clinics segment accounted for the largest share in 2024.”

In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the global genomic products market. The large share of this end-user segment can be attributed to increased patient engagement in genomic research, driven by citizen science initiatives. These efforts aim to democratize data collection and accelerate discoveries in rare diseases and personalized medicine. Additionally, pharmaceutical & biotechnology companies hold the second-largest share in this segment.

“The US dominated the North American genomics market in 2024.”

The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for genomics products & services is expected to grow over the coming years, driven by its advanced research ecosystem, strong funding support, and presence of major industry leaders such as Illumina, Thermo Fisher Scientific, Agilent Technologies, and Danaher. The country benefits from substantial government and private investments in precision medicine and population genomics programs, including NIH and All of Us initiatives. High adoption of next-generation sequencing (NGS) and bioinformatics platforms across clinical and research settings further supports market leadership. Additionally, a well-established regulatory framework, robust healthcare infrastructure, and active public–private collaborations foster continuous innovation and commercialization of genomic technologies in the US.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side (70%) and Demand Side (30%)
• By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
• By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US) are some of the key players operating in the genomics market.

Research Coverage:

This research report categorizes the genomics market by offering {products [type (reagents, kits, and consumables; instruments; and bioinformatics tools), technology (sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies), and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; CROs; and other end users)] and services [type (genomics profiling and sequencing services, sample preparation and library preparation services, and bioinformatics services) and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; and other end users)]}, application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), study type (functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The report’s scope encompasses detailed information regarding the key factors, including drivers, restraints, challenges, and opportunities, that influence market growth. A thorough analysis of key industry players has provided insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are recent developments in the genomics market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

• Analysis of key drivers (increasing government funding for genomics projects, increasing prevalence of viral and inherited disorders, advancements in NGS platforms, and growing applications of genomics), restraints (high investment costs), opportunities (increasing use of genomics in precision medicine and technological advancements in genomics), and challenges (handling of large volume of data sets and their analysis and clinical utility of genomics) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products/services of the genomics market.
• Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
• Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the genomics market.
• Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US), among others in the market.

Table of Contents

1               INTRODUCTION              44

1.1           STUDY OBJECTIVES       44

1.2           MARKET DEFINITION   44

1.3           STUDY SCOPE   44

1.3.1        MARKET SEGMENTATION & REGIONAL SCOPE 45

1.3.2        INCLUSIONS AND EXCLUSIONS 46

1.3.3        YEARS CONSIDERED      47

1.3.4        CURRENCY CONSIDERED            47

1.3.5        UNITS CONSIDERED      47

1.4           STAKEHOLDERS               47

1.5           SUMMARY OF CHANGES               48

2               RESEARCH METHODOLOGY       49

2.1           RESEARCH DATA              49

2.1.1        SECONDARY DATA          50

2.1.1.1    Key objectives of secondary research                 50

2.1.2        PRIMARY DATA 51

2.1.2.1    Breakdown of primaries      51

2.1.2.2    Key objectives of primary research    52

2.2           MARKET SIZE ESTIMATION         52

2.2.1        GLOBAL GENOMICS MARKET ESTIMATION, 2024                 52

2.2.1.1    Company revenue analysis (bottom-up approach)         53

2.2.1.2    MNM repository analysis    54

2.2.1.3    Primary research  54

2.2.2        SEGMENTAL MARKET SIZE ESTIMATION (TOP–DOWN APPROACH)       55

2.3           MARKET GROWTH RATE PROJECTIONS                58

2.4           DATA TRIANGULATION                60

2.5           STUDY ASSUMPTIONS  61

2.6           RESEARCH LIMITATIONS             62

2.7           RISK ANALYSIS  62

3               EXECUTIVE SUMMARY  63

3.1           KEY INSIGHTS & MARKET HIGHLIGHTS 63

3.2           KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS    69

3.3           DISRUPTIVE TRENDS SHAPING GENOMICS MARKET                 70

3.4           HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS                 70

4               PREMIUM INSIGHTS       71

4.1           SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST                71

4.2           NORTH AMERICA: GENOMICS MARKET, BY APPLICATION AND COUNTRY, 2024         72

4.3           GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              73

5               MARKET OVERVIEW       74

5.1           INTRODUCTION              74

5.2           MARKET DYNAMICS       74

5.2.1        DRIVERS               75

5.2.1.1    Increasing government funding for genomics projects  75

5.2.1.2    Increasing prevalence of viral and inherited disorders   76

5.2.1.3    Advancements in NGS platforms      77

5.2.1.4    Growing applications of genomics     78

5.2.2        RESTRAINTS      79

5.2.2.1    High investment costs         79

5.2.3        OPPORTUNITIES              79

5.2.3.1    Increasing use of genomics in precision medicine           79

5.2.3.2    Technological advancements in genomics        80

5.2.4        CHALLENGES    81

5.2.4.1    Handling large volumes of data sets and their analysis  81

5.2.4.2    Clinical utility of genomics 81

5.3           UNMET NEEDS AND WHITE SPACES       82

5.4           INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES              82

5.5           STRATEGIC MOVES BY TIER-1/2/3 PLAYERS        83

6               INDUSTRY TRENDS         84

6.1           PORTER’S FIVE FORCES ANALYSIS           84

6.1.1        INTENSITY OF COMPETITIVE RIVALRY 85

6.1.2        BARGAINING POWER OF SUPPLIERS       85

6.1.3        BARGAINING POWER OF BUYERS             85

6.1.4        THREAT OF SUBSTITUTES          85

6.1.5        THREAT OF NEW ENTRANTS      86

6.2           MACROECONOMIC OUTLOOK  86

6.2.1        INTRODUCTION              86

6.2.2        GDP TRENDS AND FORECAST   86

6.2.3        TRENDS IN GLOBAL GENOMICS INDUSTRY         87

6.3           VALUE CHAIN ANALYSIS               87

6.4           ECOSYSTEM ANALYSIS  89

6.4.1        EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS                 90

6.5           PRICING ANALYSIS          91

6.5.1        AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,

2022–2024              92

6.5.2        AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,

2022–2024              93

6.5.3        AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024        94

6.5.4        AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024           95

6.6           TRADE ANALYSIS             96

6.6.1        IMPORT SCENARIO (HS CODE 3822 & 902789)      96

6.6.2        EXPORT SCENARIO (HS CODE 3822 & 902789)      99

6.7           KEY CONFERENCES AND EVENTS, 2026  102

6.8           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       103

6.9           INVESTMENT AND FUNDING SCENARIO               104

6.9.1        VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE       105

6.10         CASE STUDY ANALYSIS 106

6.11         IMPACT OF 2025 US TARIFFS—GENOMICS MARKET                 107

6.11.1      INTRODUCTION              107

6.11.2      KEY TARIFF RATES          108

6.11.3      PRICE IMPACT ANALYSIS             109

6.11.4      IMPACT ON COUNTRIES/REGIONS         109

6.11.4.1  US           109

6.11.4.2  Europe   109

6.11.4.3  Asia Pacific            110

6.11.5      IMPACT ON END-USE INDUSTRIES          110

6.11.5.1  Pharmaceutical & biotechnology companies    110

6.11.5.2  CROs and academic & research institutes        111

6.11.5.3  Hospitals, diagnostic laboratories, and clinics 111

7               TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT,

PATENTS, AND INNOVATIONS  112

7.1           TECHNOLOGICAL ANALYSIS      112

7.1.1        KEY EMERGING TECHNOLOGIES              112

7.1.1.1    Sequencing by synthesis      112

7.1.1.2    Single-molecule real-time sequencing               112

7.1.1.3    Nanopore sequencing          113

7.1.1.4    qPCR      113

7.1.1.5    dPCR      114

7.1.1.6    Microarray technology         114

7.1.2        COMPLEMENTARY TECHNOLOGIES       114

7.1.2.1    Cytogenetics          114

7.1.2.2    Synthetic biology  115

7.1.2.3    Multiomics             115

7.1.2.4    Single-cell analysis                115

7.1.3        ADJACENT TECHNOLOGIES       116

7.1.3.1    Bioinformatics and computational biology       116

7.1.3.2    Artificial intelligence and machine learning     116

7.2           TECHNOLOGY/PRODUCT ROADMAP    117

7.3           PATENT ANALYSIS          117

7.3.1        TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014–2024                 118

7.4           FUTURE APPLICATIONS               120

7.5           IMPACT OF AI/GEN AI ON GENOMICS MARKET 121

7.5.1        BEST PRACTICES IN GENOMICS WORKFLOW      122

7.5.2        CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET               123

7.5.3        INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS  123

7.5.4        CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN GENOMICS MARKET       123

8               SUSTAINABILITY AND REGULATORY LANDSCAPE                 125

8.1           REGIONAL REGULATIONS AND COMPLIANCE   125

8.1.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             125

8.1.2        INDUSTRY STANDARDS                127

8.2           SUSTAINABILITY INITIATIVES   129

8.3           SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES       129

8.4           CERTIFICATIONS, LABELING, ECO-STANDARDS                 130

9               CUSTOMER LANDSCAPE & BUYER BEHAVIOR    132

9.1           DECISION-MAKING PROCESS     132

9.2           BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA             132

9.2.1        KEY STAKEHOLDERS IN BUYING PROCESS           132

9.2.2        KEY BUYING CRITERIA, BY END USER    133

9.3           ADOPTION BARRIERS & INTERNAL CHALLENGES                 134

9.4           UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES                 134

9.5           MARKET PROFITABILITY             135

10            GENOMICS MARKET, BY OFFERING         136

10.1         INTRODUCTION              137

10.2         PRODUCTS         137

10.2.1      ACCELERATION OF HIGH-THROUGHPUT GENOMICS DRIVEN BY PLATFORM INNOVATION AND AUTOMATION IS BOOSTING GROWTH     137

10.3         SERVICES             140

10.3.1      RAPID EXPANSION OF GENOMIC SERVICES FUELED BY CLINICAL ADOPTION AND DATA-DRIVEN DECISION SUPPORT                 140

11            GENOMICS PRODUCTS MARKET, BY TYPE           144

11.1         INTRODUCTION              145

11.2         REAGENTS, KITS, AND CONSUMABLES  145

11.2.1      LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR REAGENTS, KITS, AND CONSUMABLES      145

11.3         INSTRUMENTS 150

11.3.1      TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH          150

11.4         BIOINFORMATICS TOOLS            154

11.4.1      ACCELERATING GENOMIC INSIGHTS THROUGH SCALABLE, AI-ENABLED BIOINFORMATICS PLATFORMS DRIVE MARKET GROWTH          154

12            GENOMICS PRODUCTS MARKET, BY TECHNOLOGY                 158

12.1         INTRODUCTION              159

12.2         SEQUENCING    159

12.2.1      DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING

TO DRIVE MARKET GROWTH     159

12.3         PCR        163

12.3.1      RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH         163

12.4         GENE EDITING 167

12.4.1      RISING DEMAND FOR NEWER THERAPEUTIC APPROACHES DRIVING GROWTH             167

12.5         FLOW CYTOMETRY         170

12.5.1      RISING DEMAND FOR FLOW CYTOMETRY IN AGRIGENOMICS

TO DRIVE MARKET GROWTH     170

12.6         MICROARRAYS  174

12.6.1      RISING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES

LIMITING MARKET GROWTH     174

12.7         IN SITU HYBRIDIZATION              178

12.7.1      INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS

DRIVING GROWTH          178

12.8         OTHER TECHNOLOGIES               182

13            GENOMICS PRODUCTS MARKET, BY END USER 186

13.1         INTRODUCTION              187

13.2         HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS                187

13.2.1      INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH 187

13.3         ACADEMIC & RESEARCH INSTITUTES    192

13.3.1      RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH             192

13.4         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 196

13.4.1      RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS PROPELS MARKET            196

13.5         CROS     200

13.5.1      RISING COLLABORATION BETWEEN PHARMA COMPANIES AND

CROS DRIVING MARKET GROWTH           200

13.6         OTHER END USERS         204

14            GENOMICS SERVICES MARKET, BY TYPE               207

14.1         INTRODUCTION              208

14.2         GENOMIC PROFILING & SEQUENCING SERVICES                 208

14.2.1      INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH          208

14.3         SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES             212

14.3.1      INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH    212

14.4         BIOINFORMATICS SERVICES       215

14.4.1      RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH        215

15            GENOMICS SERVICES MARKET, BY END USER    219

15.1         INTRODUCTION              220

15.2         HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS                220

15.2.1      INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH 220

15.3         ACADEMIC & RESEARCH INSTITUTES    224

15.3.1      RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH             224

15.4         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 227

15.4.1      RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH        227

15.5         OTHER END USERS         231

16            GENOMICS MARKET, BY APPLICATION 235

16.1         INTRODUCTION              236

16.2         DRUG DISCOVERY & DEVELOPMENT     236

16.2.1      DRUG DISCOVERY & DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET   236

16.3         DIAGNOSTICS   240

16.3.1      CANCER DIAGNOSTICS 243

16.3.1.1  Rising demand for targeted therapies to drive market growth                 243

16.3.2      INFECTIOUS DISEASES 248

16.3.2.1  Rising demand for comprehensive genomic data in clinical genomics to drive market growth       248

16.3.3      REPRODUCTIVE HEALTH             251

16.3.3.1  Rising focus on genetic diseases to drive market growth                 251

16.3.4      OTHER DIAGNOSTIC APPLICATIONS     255

16.4         AGRICULTURE & ANIMAL RESEARCH     258

16.4.1      GENOMICS TO HELP IMPROVE CROP PRODUCTIVITY                 258

16.5         OTHER APPLICATIONS 261

17            GENOMICS MARKET, BY STUDY TYPE    265

17.1         INTRODUCTION              266

17.2         FUNCTIONAL GENOMICS            266

17.2.1      INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES

TO DRIVE MARKET GROWTH     266

17.3         BIOMARKER DISCOVERY              270

17.3.1      RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH     270

17.4         PATHWAY ANALYSIS      273

17.4.1      RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH   273

17.5         EPIGENOMICS  277

17.5.1      RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH           277

17.6         OTHER STUDY TYPES    281

18            GENOMICS MARKET, BY REGION              285

18.1         INTRODUCTION              286

18.2         NORTH AMERICA             286

18.2.1      NORTH AMERICA: MACROECONOMIC OUTLOOK                 287

18.2.2      US           292

18.2.2.1  US expected to dominate market in North America       292

18.2.3      CANADA               298

18.2.3.1  Increasing government initiatives in genomics research to boost market growth       298

18.3         EUROPE               302

18.3.1      EUROPE: MACROECONOMIC OUTLOOK               303

18.3.2      GERMANY           308

18.3.2.1  Germany to dominate European genomics market         308

18.3.3      UK          313

18.3.3.1  Strategic initiatives and funding for genomics research to support market growth       313

18.3.4      FRANCE                318

18.3.4.1  Increasing government investment in genomics research to drive growth    318

18.3.5      ITALY    322

18.3.5.1  Favorable funding scenario to drive adoption of advanced sequencing technology         322

18.3.6      SPAIN    327

18.3.6.1  Growing focus on advancements in personalized medicine to support market growth        327

18.3.7      REST OF EUROPE             332

18.4         ASIA PACIFIC     337

18.4.1      ASIA PACIFIC: MACROECONOMIC OUTLOOK     338

18.4.2      CHINA  343

18.4.2.1  China to dominate Asia Pacific market during forecast period                 343

18.4.3      JAPAN   348

18.4.3.1  Rising number of collaborations in genomics to drive market                 348

18.4.4      INDIA    352

18.4.4.1  Government and private initiatives for genomics to propel market                 352

18.4.5      AUSTRALIA         357

18.4.5.1  Increased genomics research in Australia to support market growth    357

18.4.6      SOUTH KOREA  361

18.4.6.1  Demand for advanced sequencing technologies to support market growth in South Korea            361

18.4.7      REST OF ASIA PACIFIC   366

18.5         LATIN AMERICA                371

18.5.1      LATIN AMERICA: MACROECONOMIC OUTLOOK                 371

18.5.2      BRAZIL 376

18.5.2.1  Increased government investments in genomics advancements to drive market in Brazil          376

18.5.3      MEXICO                381

18.5.3.1  Rising demand for chronic disease treatment to support market growth in Mexico 381

18.5.4      REST OF LATIN AMERICA             385

18.6         MIDDLE EAST   390

18.6.1      MIDDLE EAST: MACROECONOMIC OUTLOOK   390

18.6.2      GCC COUNTRIES              395

18.6.2.1  Saudi Arabia          400

18.6.2.1.1                Growing healthcare expenditure in Saudi Arabia to boost market growth             400

18.6.2.2  United Arab Emirates          404

18.6.2.2.1                Growing collaborations to advance genome sequencing to aid market growth in UAE              404

18.6.2.3  Rest of GCC Countries        409

18.6.3      REST OF MIDDLE EAST 414

18.7         AFRICA 418

18.7.1      GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA       418

18.7.2      AFRICA: MACROECONOMIC OUTLOOK 419

19            COMPETITIVE LANDSCAPE         424

19.1         INTRODUCTION              424

19.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            424

19.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENOMICS MARKET 425

19.3         REVENUE ANALYSIS, 2020–2024  426

19.4         MARKET SHARE ANALYSIS, 2024                 427

19.5         BRAND/PRODUCT COMPARISON             430

19.6         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 431

19.6.1      STARS   431

19.6.2      EMERGING LEADERS     431

19.6.3      PERVASIVE PLAYERS      431

19.6.4      PARTICIPANTS 431

19.6.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         433

19.6.5.1  Company footprint               433

19.6.5.2  Region footprint   434

19.6.5.3  Product footprint  435

19.6.5.4  Application footprint            436

19.6.5.5  Technology footprint           437

19.7         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        438

19.7.1      PROGRESSIVE COMPANIES         438

19.7.2      RESPONSIVE COMPANIES            438

19.7.3      DYNAMIC COMPANIES  438

19.7.4      STARTING BLOCKS         438

19.7.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 440

19.7.5.1  Detailed list of key startups/SMEs    440

19.7.5.2  Competitive benchmarking of key startups/SMEs          440

19.8         COMPANY VALUATION & FINANCIAL METRICS 441

19.8.1      FINANCIAL METRICS      441

19.8.2      COMPANY VALUATION 441

19.9         COMPETITIVE SCENARIO             442

19.9.1      PRODUCT LAUNCHES   442

19.9.2      DEALS  443

19.9.3      EXPANSIONS     443

20            COMPANY PROFILES      445

20.1         INTRODUCTION              445

20.2         KEY PLAYERS     445

20.2.1      THERMO FISHER SCIENTIFIC INC.            445

20.2.1.1  Business overview 445

20.2.1.2  Products/Services offered   446

20.2.1.3  Recent developments           451

20.2.1.3.1                Product launches and approvals         451

20.2.1.3.2                Deals      454

20.2.1.3.3                Expansions             455

20.2.1.4  MnM view              455

20.2.1.4.1                Key strengths        455

20.2.1.4.2                Strategic choices   456

20.2.1.4.3                Weaknesses and competitive threats 456

20.2.2      ILLUMINA, INC. 457

20.2.2.1  Business overview 457

20.2.2.2  Products/Services offered   458

20.2.2.3  Recent developments           461

20.2.2.3.1                Product launches and approvals         461

20.2.2.3.2                Deals      463

20.2.2.3.3                Expansions             465

20.2.2.3.4                Other developments             465

20.2.2.4  MnM view              466

20.2.2.4.1                Key strengths        466

20.2.2.4.2                Strategic choices   466

20.2.2.4.3                Weaknesses and competitive threats 466

20.2.3      DANAHER CORPORATION           467

20.2.3.1  Business overview 467

20.2.3.2  Products/Services offered   468

20.2.3.3  Recent developments           470

20.2.3.3.1                Product launches  470

20.2.3.3.2                Deals      471

20.2.3.3.3                Expansions             472

20.2.3.4  MnM view              473

20.2.3.4.1                Key strengths        473

20.2.3.4.2                Strategic choices   473

20.2.3.4.3                Weaknesses and competitive threats 473

20.2.4      F. HOFFMANN-LA ROCHE LTD. 474

20.2.4.1  Business overview 474

20.2.4.2  Products/Services offered   475

20.2.4.2.1                Product launches  477

20.2.4.2.2                Deals      478

20.2.4.2.3                Other developments             479

20.2.4.3  MnM view              479

20.2.4.3.1                Key strengths        479

20.2.4.3.2                Strategic choices   479

20.2.4.3.3                Weaknesses and competitive threats 479

20.2.5      AGILENT TECHNOLOGIES, INC.                480

20.2.5.1  Business overview 480

20.2.5.2  Products/Services offered   481

20.2.5.3  Recent developments           484

20.2.5.3.1                Product launches  484

20.2.5.3.2                Deals      485

20.2.5.3.3                Expansions             486

20.2.5.4  MnM view              487

20.2.5.4.1                Key strengths        487

20.2.5.4.2                Strategic choices   487

20.2.5.4.3                Weaknesses and competitive threats 487

20.2.6      QIAGEN                488

20.2.6.1  Business overview 488

20.2.6.2  Products/Services offered   489

20.2.6.3  Recent developments           492

20.2.6.3.1                Product launches and approvals         492

20.2.6.3.2                Deals      493

20.2.6.3.3                Expansions             495

20.2.7      REVVITY               496

20.2.7.1  Business overview 496

20.2.7.2  Products/Services offered   497

20.2.7.3  Recent developments           500

20.2.7.3.1                Product launches  500

20.2.7.3.2                Deals      501

20.2.7.3.3                Expansions             501

20.2.8      LABORATORY CORPORATION OF AMERICA HOLDINGS                 502

20.2.8.1  Business overview 502

20.2.8.2  Services offered     503

20.2.8.3  Recent developments           504

20.2.8.3.1                Service launches   504

20.2.8.3.2                Deals      505

20.2.8.3.3                Expansions             505

20.2.9      IQVIA INC.           506

20.2.9.1  Business overview 506

20.2.9.2  Services offered     507

20.2.9.3  Recent developments           508

20.2.9.3.1                Deals      508

20.2.10   CHARLES RIVER LABORATORIES               509

20.2.10.1                 Business overview 509

20.2.10.2                 Services offered     510

20.2.11   BIO-RAD LABORATORIES, INC.  511

20.2.11.1                 Business overview 511

20.2.11.2                 Products/Services offered   512

20.2.11.3                 Recent developments           514

20.2.11.3.1             Product launches and approvals         514

20.2.11.3.2             Deals      515

20.2.12   EUROFINS SCIENTIFIC  516

20.2.12.1                 Business overview 516

20.2.12.2                 Products/Services offered   517

20.2.12.3                 Recent developments           518

20.2.12.3.1             Product launches  518

20.2.12.3.2             Deals      518

20.2.13   PACBIO 519

20.2.13.1                 Business overview 519

20.2.13.2                 Products/Services offered   520

20.2.13.3                 Recent developments           522

20.2.13.3.1             Product launches  522

20.2.13.3.2             Deals      523

20.2.13.3.3             Expansions             525

20.2.13.3.4             Other developments             525

20.2.14   OXFORD NANOPORE TECHNOLOGIES PLC.        526

20.2.14.1                 Business overview 526

20.2.14.2                 Products/Services offered   527

20.2.14.3                 Recent developments           529

20.2.14.3.1             Product launches  529

20.2.14.3.2             Deals      529

20.2.14.3.3             Expansions             532

20.2.15   TAKARA BIO INC.             533

20.2.15.1                 Business overview 533

20.2.15.2                 Products/Services offered   534

20.2.15.3                 Recent developments           538

20.2.15.3.1             Product launches  538

20.2.15.3.2             Deals      538

20.2.16   BGI GROUP         539

20.2.16.1                 Business overview 539

20.2.16.2                 Products/Services offered   539

20.2.16.3                 Recent developments           543

20.2.16.3.1             Product & service launches and approvals       543

20.2.16.3.2             Deals      544

20.2.16.3.3             Other developments             545

20.2.17   EPPENDORF SE 546

20.2.17.1                 Business overview 546

20.2.17.2                 Products/Services offered   547

20.2.17.3                 Recent developments           548

20.2.17.3.1             Product launches  548

20.2.18   MERCK KGAA    549

20.2.18.1                 Business overview 549

20.2.18.2                 Products/Services offered   550

20.2.18.3                 Recent developments           551

20.2.18.3.1             Deals      551

20.2.18.3.2             Expansions             552

20.2.19   BD          553

20.2.19.1                 Business overview 553

20.2.19.2                 Products/Services offered   554

20.2.19.3                 Recent developments           556

20.2.19.3.1             Product launches and approvals         556

20.2.19.3.2             Deals      557

20.2.20   ABBOTT               558

20.2.20.1                 Business overview 558

20.2.20.2                 Products/Services offered   559

20.2.21   10X GENOMICS 562

20.2.21.1                 Business overview 562

20.2.21.2                 Products/Services offered   563

20.2.21.3                 Recent developments           565

20.2.21.3.1             Product launches  565

20.2.22   NEW ENGLAND BIOLABS              566

20.2.22.1                 Business overview 566

20.2.22.2                 Products/Services offered   566

20.2.22.3                 Recent developments           569

20.2.22.3.1             Product launches  569

20.2.22.3.2             Deals      570

20.2.23   PROMEGA CORPORATION           571

20.2.23.1                 Business overview 571

20.2.23.2                 Products/Services offered   571

20.2.23.3                 Recent developments           572

20.2.23.3.1             Product launches  572

20.2.23.3.2             Other developments             573

20.3         OTHER PLAYERS              574

20.3.1      CREATIVE BIOGENE       574

20.3.2      NOVOGENE CO., LTD.   575

20.3.3      HELIX, INC.         576

20.3.4      PHALANX BIOTECH GROUP        577

20.3.5      POLARIS GENOMICS      578

21            APPENDIX           579

21.1         DISCUSSION GUIDE        579

21.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                584

21.3         CUSTOMIZATION OPTIONS        586

21.4         RELATED REPORTS         587

21.5         AUTHOR DETAILS           588

LIST OF TABLES

TABLE 1                GENOMICS MARKET: INCLUSIONS & EXCLUSIONS      46

TABLE 2                IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS  59

TABLE 3                GENOMICS MARKET: RISK ANALYSIS      62

TABLE 4                GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS       75

TABLE 5                GENOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES      85

TABLE 6                GENOMICS MARKET: ROLE IN ECOSYSTEM                 89

TABLE 7                GENOMICS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS                 90

TABLE 8                AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,

2022–2024 (USD)                                 92

TABLE 9                AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,

2022–2024 (USD)                                 93

TABLE 10              AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)        94

TABLE 11              AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION,

2022–2024 (USD)                                 95

TABLE 12              IMPORT VALUE FOR HS CODE 3822, 2020–2024 (USD THOUSAND)           96

TABLE 13              IMPORT VOLUME FOR HS CODE 3822, 2020–2024 (TONS) 97

TABLE 14              IMPORT VALUE FOR HS CODE 902789, 2022–2024 (USD THOUSAND)           98

TABLE 15              IMPORT VOLUME FOR HS CODE 902789, 2022–2024 (UNITS)      98

TABLE 16              EXPORT VALUE FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND)               99

TABLE 17              EXPORT VOLUME FOR HS CODE 3822, BY COUNTRY, 2019–2023 (TONS)     100

TABLE 18              EXPORT VALUE FOR HS CODE 902789, 2022–2024 (USD THOUSAND)           101

TABLE 19              EXPORT VOLUME FOR HS CODE 902789, 2022–2024 (UNITS)      102

TABLE 20              GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2026     102

TABLE 21              SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER

CONTRIBUTING TO IVF FAILURES           106

TABLE 22              LONG-READ WHOLE GENOME SEQUENCING WAS USED IN

CHILDREN’S MERCY KANSAS CITY           107

TABLE 23              US-ADJUSTED RECIPROCAL TARIFF RATES                 108

TABLE 24              GENOMICS MARKET: INDICATIVE LIST OF PATENTS, 2025  119

TABLE 25              CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET       123

TABLE 26              CLIENT’S READINESS TO ADOPT GENERATIVE AI IN GENOMICS               124

TABLE 27              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  125

TABLE 28              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  125

TABLE 29              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 126

TABLE 30              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  127

TABLE 31              US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION        128

TABLE 32              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              128

TABLE 33              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)        132

TABLE 34              KEY BUYING CRITERIA, BY END USER    133

TABLE 35              GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 137

TABLE 36              GENOMICS PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)            138

TABLE 37              NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 38              EUROPE: GENOMICS PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 39              ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 40              LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 41              MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            139

TABLE 42              GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 43              GENOMICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            141

TABLE 44              NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            141

TABLE 45              EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            141

TABLE 46              ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 47             LATIN AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 48              MIDDLE EAST: GENOMICS SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            142

TABLE 49              GCC COUNTRIES: GENOMICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            143

TABLE 50              GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       145

TABLE 51              GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION,

2023–2030 (USD MILLION)            147

TABLE 52              NORTH AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               147

TABLE 53              EUROPE: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 54              ASIA PACIFIC: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 55              LATIN AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 56              MIDDLE EAST: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,

BY REGION, 2023–2030 (USD MILLION)   149

TABLE 57              GCC COUNTRIES: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 58              GENOMICS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)          151

TABLE 59              NORTH AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 60              EUROPE: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            152

TABLE 61              ASIA PACIFIC: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          152

TABLE 62              LATIN AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 63              MIDDLE EAST: GENOMICS INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            153

TABLE 64              GCC COUNTRIES: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 65              GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION,

2023–2030 (USD MILLION)            155

TABLE 66              NORTH AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155

TABLE 67              EUROPE: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 68              ASIA PACIFIC: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 69              LATIN AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 157

TABLE 70              MIDDLE EAST: GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION,

2023–2030 (USD MILLION)            157

TABLE 71              GCC COUNTRIES: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 157

TABLE 72              GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            159

TABLE 73              SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)            160

TABLE 74              NORTH AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 75              EUROPE: SEQUENCING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 76              ASIA PACIFIC: SEQUENCING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 77              LATIN AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 78              MIDDLE EAST: SEQUENCING PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            162

TABLE 79              GCC COUNTRIES: SEQUENCING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 80              SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS)            163

TABLE 81              PCR PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 164

TABLE 82              NORTH AMERICA: PCR PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            164

TABLE 83              EUROPE: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     165

TABLE 84              ASIA PACIFIC: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     165

TABLE 85              LATIN AMERICA: PCR PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            166

TABLE 86              MIDDLE EAST: PCR PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          166

TABLE 87              GCC COUNTRIES: PCR PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            166

TABLE 88              GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          167

TABLE 89              NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 90              EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 91              ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            169

TABLE 92              LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            169

TABLE 93              MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            169

TABLE 94              GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            170

TABLE 95              FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          171

TABLE 96              NORTH AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            171

TABLE 97              EUROPE: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            172

TABLE 98              ASIA PACIFIC: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            172

TABLE 99              LATIN AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            173

TABLE 100            MIDDLE EAST: FLOW CYTOMETRY PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            173

TABLE 101            GCC COUNTRIES: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            173

TABLE 102            FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2023–2030 (UNITS)               174

TABLE 103            MICROARRAY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)            175

TABLE 104            NORTH AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            175

TABLE 105            EUROPE: MICROARRAY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            176

TABLE 106            ASIA PACIFIC: MICROARRAY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            176

TABLE 107            LATIN AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            177

TABLE 108            MIDDLE EAST: MICROARRAY PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            177

TABLE 109            GCC COUNTRIES: MICROARRAY PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            177

TABLE 110            IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            179

TABLE 111            NORTH AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 179

TABLE 112            EUROPE: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            180

TABLE 113            ASIA PACIFIC: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            180

TABLE 114            LATIN AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 181

TABLE 115            MIDDLE EAST: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            181

TABLE 116            GCC COUNTRIES: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 181

TABLE 117            GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION,

2023–2030 (USD MILLION)            182

TABLE 118            NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               183

TABLE 119            EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               183

TABLE 120            ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               184

TABLE 121            LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               184

TABLE 122            MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY REGION, 2023–2030 (USD MILLION)   184

TABLE 123            GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               185

TABLE 124            GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)            187

TABLE 125            GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)          189

TABLE 126            NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            189

TABLE 127            EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)     190

TABLE 128            ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)               190

TABLE 129            LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            191

TABLE 130            MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)   191

TABLE 131            GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            191

TABLE 132            GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY REGION, 2023–2030 (USD MILLION)   193

TABLE 133            NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     193

TABLE 134            EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194

TABLE 135            ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)       194

TABLE 136            LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     195

TABLE 137            MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)       195

TABLE 138            GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     195

TABLE 139            GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          197

TABLE 140            NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   197

TABLE 141            EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     198

TABLE 142            ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     198

TABLE 143            LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   199

TABLE 144            MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          199

TABLE 145            GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   199

TABLE 146            GENOMICS PRODUCTS MARKET FOR CROS, BY REGION,

2023–2030 (USD MILLION)            201

TABLE 147            NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS,

BY COUNTRY, 2023–2030 (USD MILLION)               201

TABLE 148            EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,

2023–2030 (USD MILLION)            202

TABLE 149            ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,

2023–2030 (USD MILLION)            202

TABLE 150            LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,

2023–2030 (USD MILLION)          203

TABLE 151            MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION,

2023–2030 (USD MILLION)            203

TABLE 152            GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,

2023–2030 (USD MILLION)            203

TABLE 153            GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            204

TABLE 154            NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 155            EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 205

TABLE 156            ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               205

TABLE 157            LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 158            MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,

BY REGION, 2023–2030 (USD MILLION)   206

TABLE 159            GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 160            GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)       208

TABLE 161            GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            209

TABLE 162            NORTH AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               209

TABLE 163            EUROPE: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 210

TABLE 164            ASIA PACIFIC: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               210

TABLE 165            LATIN AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 166            MIDDLE EAST: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   211

TABLE 167            GCC COUNTRIES: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 168            SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            212

TABLE 169            NORTH AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       213

TABLE 170            EUROPE: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 171            ASIA PACIFIC: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       214

TABLE 172            LATIN AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       214

TABLE 173            MIDDLE EAST: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)       214

TABLE 174            GCC COUNTRIES: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       215

TABLE 175            BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          216

TABLE 176            NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            216

TABLE 177            EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            217

TABLE 178            ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            217

TABLE 179            LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            218

TABLE 180            MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            218

TABLE 181            GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            218

TABLE 182            GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            220

TABLE 183            GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)       221

TABLE 184            NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            221

TABLE 185            EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)     222

TABLE 186            ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 187            LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)               223

TABLE 188            MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION)   223

TABLE 189            GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            223

TABLE 190            GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY REGION, 2023–2030 (USD MILLION)   224

TABLE 191            NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     225

TABLE 192            EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 225

TABLE 193            ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)       226

TABLE 194            LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)       226

TABLE 195            MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)       226

TABLE 196            GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     227

TABLE 197            GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          228

TABLE 198            NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     228

TABLE 199            EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     229

TABLE 200            ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     229

TABLE 201            LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     230

TABLE 202            MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          230

TABLE 203            GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   230

TABLE 204            GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            232

TABLE 205            NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 206            EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 207            ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 208            LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 209            MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS,

BY REGION, 2023–2030 (USD MILLION)   234

TABLE 210            GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 211            GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)       236

TABLE 212            GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION,

2023–2030 (USD MILLION)            237

TABLE 213            NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 237

TABLE 214            EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               238

TABLE 215            ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               238

TABLE 216            LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 217            MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY REGION, 2023–2030 (USD MILLION)   239

TABLE 218            GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 239

TABLE 219            GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)          240

TABLE 220            NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            241

TABLE 221            EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            241

TABLE 222            ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            242

TABLE 223            LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            242

TABLE 224            MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION,

2023–2030 (USD MILLION)            242

TABLE 225            GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            243

TABLE 226            GENOMICS MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                243

TABLE 227            GRANTS, BY CANCER TYPE (AS OF OCTOBER 2025)      244

TABLE 228            GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION,

2023–2030 (USD MILLION)            245

TABLE 229            NORTH AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)            245

TABLE 230            EUROPE: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            246

TABLE 231            ASIA PACIFIC: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)            246

TABLE 232            LATIN AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)            247

TABLE 233            MIDDLE EAST: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)                 247

TABLE 234            GCC COUNTRIES: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)            247

TABLE 235            GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION,

2023–2030 (USD MILLION)            248

TABLE 236            NORTH AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)                 249

TABLE 237            EUROPE: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,

2023–2030 (USD MILLION)            249

TABLE 238            ASIA PACIFIC: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)                 250

TABLE 239            LATIN AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)                 250

TABLE 240            MIDDLE EAST: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)                 250

TABLE 241            GCC COUNTRIES: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)                 251

TABLE 242            GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION,

2023–2030 (USD MILLION)            252

TABLE 243            NORTH AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)            252

TABLE 244            EUROPE: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY,

2023–2030 (USD MILLION)            253

TABLE 245            ASIA PACIFIC: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)            253

TABLE 246            LATIN AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)            254

TABLE 247            MIDDLE EAST: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023–2030 (USD MILLION)            254

TABLE 248            GCC COUNTRIES: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)            254

TABLE 249            GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            255

TABLE 250            NORTH AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               255

TABLE 251            EUROPE: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               256

TABLE 252            ASIA PACIFIC: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)             256

TABLE 253            LATIN AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               257

TABLE 254            MIDDLE EAST: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   257

TABLE 255            GCC COUNTRIES: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               257

TABLE 256            GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION,

2023–2030 (USD MILLION)            258

TABLE 257            NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 259

TABLE 258            EUROPE: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               259

TABLE 259            ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               260

TABLE 260            LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               260

TABLE 261            MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,

BY REGION, 2023–2030 (USD MILLION)   260

TABLE 262            GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 261

TABLE 263            GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            261

TABLE 264            NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            262

TABLE 265            EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            262

TABLE 266            ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 263

TABLE 267            LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            263

TABLE 268            MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            263

TABLE 269            GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            264

TABLE 270            GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 266

TABLE 271            GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION,

2023–2030 (USD MILLION)            267

TABLE 272            NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)            267

TABLE 273            EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY,

2023–2030 (USD MILLION)            268

TABLE 274            ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)            268

TABLE 275            LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)            269

TABLE 276            MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023–2030 (USD MILLION)            269

TABLE 277            GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)            269

TABLE 278            GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION,

2023–2030 (USD MILLION)            270

TABLE 279            NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)            271

TABLE 280            EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY,

2023–2030 (USD MILLION)            271

TABLE 281            ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)            272

TABLE 282            LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)            272

TABLE 283            MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023–2030 (USD MILLION)                 272

TABLE 284            GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)            273

TABLE 285            GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION,

2023–2030 (USD MILLION)            274

TABLE 286            NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)                 274

TABLE 287            EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY,

2023–2030 (USD MILLION)            275

TABLE 288            ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY,

2023–2030 (USD MILLION)            275

TABLE 289            LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)                 276

TABLE 290            MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION,

2023–2030 (USD MILLION)            276

TABLE 291            GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)                 276

TABLE 292            GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023–2030 (USD MILLION)          278

TABLE 293            NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,

2023–2030 (USD MILLION)            278

TABLE 294            EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,

2023–2030 (USD MILLION)            279

TABLE 295            ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,

2023–2030 (USD MILLION)            279

TABLE 296            LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,

2023–2030 (USD MILLION)            280

TABLE 297            MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION,

2023–2030 (USD MILLION)            280

TABLE 298            GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,

2023–2030 (USD MILLION)          280

TABLE 299            GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION,

2023–2030 (USD MILLION)            282

TABLE 300            NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)                 282

TABLE 301            EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY,

2023–2030 (USD MILLION)          283

TABLE 302            ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY,

2023–2030 (USD MILLION)            283

TABLE 303            LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)                 284

TABLE 304            MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION,

2023–2030 (USD MILLION)            284

TABLE 305            GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION)                 284

TABLE 306            GENOMICS MARKET, BY REGION, 2023–2030 (USD MILLION) 286

TABLE 307            NORTH AMERICA: KEY MACROINDICATORS                 288

TABLE 308            NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     288

TABLE 309            NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     288

TABLE 310            NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            289

TABLE 311            NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            289

TABLE 312            NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)          290

TABLE 313            NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            290

TABLE 314            NORTH AMERICA: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            291

TABLE 315            NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            291

TABLE 316            NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            292

TABLE 317            NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)          292

TABLE 318            US: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)       294

TABLE 319            US: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            294

TABLE 320            US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            294

TABLE 321            US: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                295

TABLE 322            US: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 323            US: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            296

TABLE 324            US: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 325            US: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)       297

TABLE 326            US: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                297

TABLE 327            CANADA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            299

TABLE 328            CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                299

TABLE 329            CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            299

TABLE 330            CANADA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            300

TABLE 331            CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                300

TABLE 332            CANADA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              301

TABLE 333            CANADA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            301

TABLE 334            CANADA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            302

TABLE 335            CANADA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            302

TABLE 336            EUROPE: KEY MACROINDICATORS          303

TABLE 337            EUROPE: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            304

TABLE 338            EUROPE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            304

TABLE 339            EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                304

TABLE 340            EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            305

TABLE 341            EUROPE: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            305

TABLE 342            EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                306

TABLE 343            EUROPE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              306

TABLE 344            EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            307

TABLE 345            EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            307

TABLE 346            EUROPE: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            308

TABLE 347            GERMANY: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            309

TABLE 348            GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                309

TABLE 349            GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            310

TABLE 350            GERMANY: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            310

TABLE 351            GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                311

TABLE 352            GERMANY: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              311

TABLE 353            GERMANY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            312

TABLE 354            GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                312

TABLE 355            GERMANY: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            313

TABLE 356            UK: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)       314

TABLE 357            UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            314

TABLE 358            UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            315

TABLE 359            UK: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                315

TABLE 360            UK: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            316

TABLE 361            UK: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            316

TABLE 362            UK: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            317

TABLE 363            UK: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)       317

TABLE 364            UK: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                318

TABLE 365            FRANCE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            319

TABLE 366            FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                319

TABLE 367            FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            319

TABLE 368            FRANCE: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            320

TABLE 369            FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                320

TABLE 370          FRANCE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            321

TABLE 371            FRANCE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            321

TABLE 372            FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            322

TABLE 373            FRANCE: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            322

TABLE 374            ITALY: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            323

TABLE 375            ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                324

TABLE 376            ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            324

TABLE 377            ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                325

TABLE 378            ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            325

TABLE 379            ITALY: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            326

TABLE 380            ITALY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            326

TABLE 381            ITALY: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            327

TABLE 382            ITALY: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                327

TABLE 383            SPAIN: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            328

TABLE 384            SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                328

TABLE 385            SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            329

TABLE 386            SPAIN: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            329

TABLE 387            SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            330

TABLE 388            SPAIN: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            330

TABLE 389            SPAIN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            331

TABLE 390            SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            331

TABLE 391            SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                332

TABLE 392            REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     333

TABLE 393            REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            333

TABLE 394            REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            334

TABLE 395            REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            334

TABLE 396            REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            335

TABLE 397            REST OF EUROPE: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            335

TABLE 398            REST OF EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            336

TABLE 399            REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            336

TABLE 400            REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            337

TABLE 401            ASIA PACIFIC: KEY MACROINDICATORS                 339

TABLE 402            ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     339

TABLE 403            ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     340

TABLE 404            ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            340

TABLE 405            ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            340

TABLE 406            ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            341

TABLE 407            ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            341

TABLE 408            ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              342

TABLE 409            ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         342

TABLE 410            ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                343

TABLE 411            ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            343

TABLE 412            CHINA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            344

TABLE 413            CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                344

TABLE 414            CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            345

TABLE 415            CHINA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            345

TABLE 416          CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            346

TABLE 417            CHINA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            346

TABLE 418            CHINA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            347

TABLE 419            CHINA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            347

TABLE 420            CHINA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                348

TABLE 421            JAPAN: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            349

TABLE 422            JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                349

TABLE 423            JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            349

TABLE 424            JAPAN: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            350

TABLE 425            JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            350

TABLE 426            JAPAN: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            351

TABLE 427            JAPAN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            351

TABLE 428            JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            352

TABLE 429            JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                352

TABLE 430            INDIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            353

TABLE 431            INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                353

TABLE 432            INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            354

TABLE 433            INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                354

TABLE 434            INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            355

TABLE 435            INDIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            355

TABLE 436            INDIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            356

TABLE 437            INDIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            356

TABLE 438            INDIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                357

TABLE 439          AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            358

TABLE 440            AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)         358

TABLE 441            AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            358

TABLE 442            AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            359

TABLE 443            AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                359

TABLE 444            AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              360

TABLE 445            AUSTRALIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 446            AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                361

TABLE 447            AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            361

TABLE 448            SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     362

TABLE 449            SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            362

TABLE 450            SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            363

TABLE 451            SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            363

TABLE 452            SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            364

TABLE 453            SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              364

TABLE 454            SOUTH KOREA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            365

TABLE 455            SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                365

TABLE 456            SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            366

TABLE 457            REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING,

2023–2030 (USD MILLION)            367

TABLE 458            REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            367

TABLE 459            REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            368

TABLE 460            REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            368

TABLE 461            REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            369

TABLE 462            REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            369

TABLE 463            REST OF ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         370

TABLE 464            REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            370

TABLE 465            REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            371

TABLE 466            LATIN AMERICA: KEY MACROINDICATORS                 372

TABLE 467            LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     372

TABLE 468            LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     373

TABLE 469            LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            373

TABLE 470            LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            373

TABLE 471            LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            374

TABLE 472          LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 473            LATIN AMERICA: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            375

TABLE 474            LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         375

TABLE 475            LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                376

TABLE 476          LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            376

TABLE 477            BRAZIL: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            377

TABLE 478            BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                377

TABLE 479            BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)          378

TABLE 480            BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            378

TABLE 481            BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                379

TABLE 482            BRAZIL: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            379

TABLE 483            BRAZIL: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            380

TABLE 484            BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            380

TABLE 485            BRAZIL: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            381

TABLE 486            MEXICO: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            382

TABLE 487            MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                382

TABLE 488            MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            382

TABLE 489            MEXICO: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            383

TABLE 490            MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                383

TABLE 491          MEXICO: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            384

TABLE 492            MEXICO: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            384

TABLE 493            MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            385

TABLE 494            MEXICO: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            385

TABLE 495            REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING,

2023–2030 (USD MILLION)            386

TABLE 496            REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            386

TABLE 497            REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            387

TABLE 498            REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            387

TABLE 499            REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 500            REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            388

TABLE 501            REST OF LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         389

TABLE 502            REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            389

TABLE 503            REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            390

TABLE 504            MIDDLE EAST: KEY MACROINDICATORS                 391

TABLE 505          MIDDLE EAST: GENOMICS MARKET, BY REGION, 2023–2030 (USD MILLION)            391

TABLE 506            MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     391

TABLE 507            MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            392

TABLE 508            MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            392

TABLE 509            MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            393

TABLE 510            MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            393

TABLE 511            MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              394

TABLE 512            MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            394

TABLE 513            MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                395

TABLE 514            MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            395

TABLE 515            GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     396

TABLE 516            GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     396

TABLE 517            GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            396

TABLE 518            GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            397

TABLE 519            GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            397

TABLE 520            GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            398

TABLE 521            GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            398

TABLE 522            GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            399

TABLE 523            GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            399

TABLE 524            GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)          400

TABLE 525            SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)     401

TABLE 526          SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            401

TABLE 527          SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)          401

TABLE 528            SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER,

2023–2030 (USD MILLION)            402

TABLE 529            SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 530            SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              403

TABLE 531            SAUDI ARABIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         403

TABLE 532            SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)                404

TABLE 533            SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            404

TABLE 534            UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING,

2023–2030 (USD MILLION)            405

TABLE 535            UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            405

TABLE 536            UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            406

TABLE 537            UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER,

2023–2030 (USD MILLION)            406

TABLE 538            UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            407

TABLE 539            UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            407

TABLE 540            UNITED ARAB EMIRATES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 541            UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)          408

TABLE 542            UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            409

TABLE 543            REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING,

2023–2030 (USD MILLION)            410

TABLE 544            REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            410

TABLE 545            REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            411

TABLE 546            REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            411

TABLE 547            REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            412

TABLE 548            REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            412

TABLE 549            REST OF GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            413

TABLE 550            REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            413

TABLE 551            REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            414

TABLE 552            REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING,

2023–2030 (USD MILLION)            415

TABLE 553            REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)          415

TABLE 554            REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            415

TABLE 555            REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            416

TABLE 556            REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            416

TABLE 557            REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            417

TABLE 558            REST OF MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         417

TABLE 559            REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE,

2023–2030 (USD MILLION)            418

TABLE 560            REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            418

TABLE 561            AFRICA: KEY MACROINDICATORS            419

TABLE 562            AFRICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION)            420

TABLE 563            AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                420

TABLE 564            AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            420

TABLE 565            AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION)     421

TABLE 566            AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                421

TABLE 567            AFRICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            422

TABLE 568            AFRICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            422

TABLE 569            AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION)            423

TABLE 570            AFRICA: GENOMICS SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            423

TABLE 571            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENOMICS MARKET, JANUARY 2022−OCTOBER 2025        425

TABLE 572            GENOMICS PRODUCTS MARKET: DEGREE OF COMPETITION 428

TABLE 573            MARKET RANK OF KEY PLAYERS IN GENOMICS SERVICES MARKET (2024)             429

TABLE 574            GENOMICS MARKET: REGION FOOTPRINT                 434

TABLE 575            GENOMICS MARKET: PRODUCT FOOTPRINT                 435

TABLE 576            GENOMICS MARKET: APPLICATION FOOTPRINT       436

TABLE 577            GENOMICS MARKET: TECHNOLOGY FOOTPRINT       437

TABLE 578            GENOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS               440

TABLE 579            GENOMICS MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SME PLAYERS    440

TABLE 580            GENOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2022—OCTOBER 2025 442

TABLE 581            GENOMICS MARKET: DEALS, JANUARY 2022—OCTOBER 2025  443

TABLE 582            GENOMICS MARKET: EXPANSIONS, JANUARY 2022—OCTOBER 2025     443

TABLE 583            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          445

TABLE 584            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED               446

TABLE 585            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025                 451

TABLE 586            THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–OCTOBER 2025   454

TABLE 587          THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025   455

TABLE 588            ILLUMINA, INC.: COMPANY OVERVIEW 457

TABLE 589            ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED             458

TABLE 590            ILLUMINA, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–OCTOBER 2025   461

TABLE 591            ILLUMINA, INC.: DEALS, JANUARY 2022–OCTOBER 2025  463

TABLE 592            ILLUMINA, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025  465

TABLE 593            ILLUMINA, INC.: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025   465

TABLE 594            DANAHER CORPORATION: COMPANY OVERVIEW          467

TABLE 595            DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED               468

TABLE 596            DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025           470

TABLE 597            DANAHER CORPORATION: DEALS, JANUARY 2022–OCTOBER 2025        471

TABLE 598            DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–OCTOBER 2025   472

TABLE 599            F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW          474

TABLE 600            F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED               475

TABLE 601            F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES,

JANUARY 2022–OCTOBER 2025 477

TABLE 602            F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–OCTOBER 2025   478

TABLE 603            F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS,

JANUARY 2022–OCTOBER 2025   479

TABLE 604            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          480

TABLE 605            AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED               481

TABLE 606            AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,

JANUARY 2022–OCTOBER 2025   484

TABLE 607            AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–OCTOBER 2025   485

TABLE 608            AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025   486

TABLE 609            QIAGEN: COMPANY OVERVIEW 488

TABLE 610            QIAGEN: PRODUCTS/SERVICES OFFERED                 489

TABLE 611            QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025         492

TABLE 612            QIAGEN: DEALS, JANUARY 2022–OCTOBER 2025                 493

TABLE 613            QIAGEN: EXPANSIONS, JANUARY 2022–OCTOBER 2025  495

TABLE 614            REVVITY: COMPANY OVERVIEW               496

TABLE 615            REVVITY: PRODUCTS/SERVICES OFFERED                 497

TABLE 616            REVVITY: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025  500

TABLE 617            REVVITY: DEALS, JANUARY 2022–OCTOBER 2025                 501

TABLE 618            REVVITY: EXPANSIONS, JANUARY 2022–OCTOBER 2025  501

TABLE 619            LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW          502

TABLE 620            LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED               503

TABLE 621            LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2022–OCTOBER 2025                 504

TABLE 622            LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2022–OCTOBER 2025           505

TABLE 623            LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2022–OCTOBER 2025                 505

TABLE 624            IQVIA INC.: COMPANY OVERVIEW            506

TABLE 625            IQVIA INC.: SERVICES OFFERED 507

TABLE 626            IQVIA INC.: DEALS, JANUARY 2022–OCTOBER 2025        508

TABLE 627            CHARLES RIVER LABORATORIES: COMPANY OVERVIEW          509

TABLE 628            CHARLES RIVER LABORATORIES: SERVICES OFFERED             510

TABLE 629            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          511

TABLE 630            BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED               512

TABLE 631            BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025                 514

TABLE 632            BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022–OCTOBER 2025   515

TABLE 633            EUROFINS SCIENTIFIC: COMPANY OVERVIEW                 516

TABLE 634            EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED             517

TABLE 635            EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025   518

TABLE 636            EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–OCTOBER 2025  518

TABLE 637            PACBIO: COMPANY OVERVIEW 519

TABLE 638            PACBIO: PRODUCTS/SERVICES OFFERED                 520

TABLE 639            PACBIO: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025  522

TABLE 640            PACBIO: DEALS, JANUARY 2022–OCTOBER 2025                 523

TABLE 641            PACBIO: EXPANSIONS, JANUARY 2022–OCTOBER 2025  525

TABLE 642            PACBIO: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025        525

TABLE 643            OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW   526

TABLE 644            OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED               527

TABLE 645            OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT LAUNCHES,

JANUARY 2022–OCTOBER 2025   529

TABLE 646            OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS,

JANUARY 2022–OCTOBER 2025   529

TABLE 647            OXFORD NANOPORE TECHNOLOGIES PLC.: EXPANSIONS,

JANUARY 2022–OCTOBER 2025   532

TABLE 648            TAKARA BIO INC.: COMPANY OVERVIEW                 533

TABLE 649            TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED             534

TABLE 650            TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025   538

TABLE 651            TAKARA BIO INC.: DEALS, JANUARY 2022–OCTOBER 2025  538

TABLE 652            BGI GROUP: COMPANY OVERVIEW         539

TABLE 653            BGI GROUP: PRODUCTS/SERVICES OFFERED                 539

TABLE 654            BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS,

JANUARY 2022–OCTOBER 2025   543

TABLE 655            BGI GROUP: DEALS, JANUARY 2022–OCTOBER 2025        544

TABLE 656            BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025        545

TABLE 657            EPPENDORF SE: COMPANY OVERVIEW 546

TABLE 658            EPPENDORF SE: PRODUCTS/SERVICES OFFERED             547

TABLE 659            EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025   548

TABLE 660            MERCK KGAA: COMPANY OVERVIEW     549

TABLE 661            MERCK KGAA: PRODUCTS/SERVICES OFFERED                 550

TABLE 662            MERCK KGAA: DEALS, JANUARY 2022–OCTOBER 2025        551

TABLE 663            MERCK KGAA: EXPANSIONS, JANUARY 2022–OCTOBER 2025  552

TABLE 664            BD: COMPANY OVERVIEW           553

TABLE 665            BD: PRODUCTS/SERVICES OFFERED      554

TABLE 666            BD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025   556

TABLE 667            BD: DEALS, JANUARY 2022–OCTOBER 2025                 557

TABLE 668            ABBOTT: COMPANY OVERVIEW                558

TABLE 669            ABBOTT: PRODUCTS/SERVICES OFFERED                 559

TABLE 670            10X GENOMICS: COMPANY OVERVIEW  562

TABLE 671            10X GENOMICS: PRODUCTS/SERVICES OFFERED             563

TABLE 672            10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025   565

TABLE 673            NEW ENGLAND BIOLABS: COMPANY OVERVIEW                 566

TABLE 674            NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED             566

TABLE 675          NEW ENGLAND BIOLABS: PRODUCT LAUNCHES,

JANUARY 2021– SEPTEMBER 2024               569

TABLE 676            NEW ENGLAND BIOLABS: DEALS, JANUARY 2022–OCTOBER 2025        570

TABLE 677            PROMEGA CORPORATION: COMPANY OVERVIEW          571

TABLE 678            PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED               571

TABLE 679            PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025           572

TABLE 680            PROMEGA CORPORATION: OTHER DEVELOPMENTS,

JANUARY 2022–OCTOBER 2025   573

TABLE 681            CREATIVE BIOGENE: COMPANY OVERVIEW                 574

TABLE 682            NOVOGENE CO., LTD.: COMPANY OVERVIEW                 575

TABLE 683            HELIX, INC.: COMPANY OVERVIEW          576

TABLE 684            PHALANX BIOTECH GROUP: COMPANY OVERVIEW          577

TABLE 685            POLARIS GENOMICS: COMPANY OVERVIEW                 578

LIST OF FIGURES

FIGURE 1              GENOMICS MARKET SEGMENTATION & REGIONAL SCOPE            45

FIGURE 2              GENOMICS MARKET: YEARS CONSIDERED                 47

FIGURE 3              GENOMICS MARKET: RESEARCH DESIGN                 49

FIGURE 4              GENOMICS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND

SUPPLY-SIDE PARTICIPANTS)    51

FIGURE 5              GLOBAL GENOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024  52

FIGURE 6              GLOBAL GENOMICS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM–UP APPROACH), 2024             53

FIGURE 7              GENOMICS MARKET SIZE VALIDATION FROM INDUSTRY EXPERTS       54

FIGURE 8              SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH          55

FIGURE 9              GENOMICS PRODUCTS MARKET, BY TECHNOLOGY (COMPANY REVENUE ANALYSIS)               56

FIGURE 10            GLOBAL GENOMICS MARKET: CAGR PROJECTIONS (2025–2030)            58

FIGURE 11            DATA TRIANGULATION                60

FIGURE 12            GENOMICS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)       63

FIGURE 13            GENOMICS PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)                64

FIGURE 14            GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)      64

FIGURE 15            GENOMICS PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      65

FIGURE 16           GENOMICS SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)       66

FIGURE 17            GENOMICS SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      66

FIGURE 18            GENOMICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)       67

FIGURE 19            GENOMICS MARKET, BY STUDY TYPE, 2025 VS. 2030 (USD MILLION)       68

FIGURE 20            REGIONAL SNAPSHOT OF GENOMICS MARKET                 69

FIGURE 21            INCREASING GOVERNMENT FUNDING FOR GENOMICS PROJECTS

TO PROPEL MARKET GROWTH 71

FIGURE 22            US AND DRUG DISCOVERY & DEVELOPMENT COMMANDED LARGEST MARKET SHARES IN 2024            72

FIGURE 23            CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 73

FIGURE 24            GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES     74

FIGURE 25            BURDEN OF HIV INFECTIONS, BY REGION, 2024                 77

FIGURE 26            GENOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS            84

FIGURE 27            GROWTH OF GLOBAL GDP FROM 2020 TO 2024, WITH FORECASTS UNTIL 2030    87

FIGURE 28            GENOMICS MARKET: VALUE CHAIN ANALYSIS                 88

FIGURE 29            GENOMICS MARKET ECOSYSTEM            89

FIGURE 30            AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,

2022–2024 (USD)                93

FIGURE 31            AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,

2022–2024 (USD)                94

FIGURE 32            AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION,

2022–2024 (USD)                96

FIGURE 33            REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS

IN GENOMICS MARKET 103

FIGURE 34            PE/VC INVESTMENTS IN LIFE SCIENCES SPLIT BETWEEN PHARMACEUTICALS

AND HEALTHCARE          105

FIGURE 35            TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014–2024                 118

FIGURE 36            IMPACT OF AI/GEN AI ON GENOMICS MARKET                 122

FIGURE 37            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING                132

FIGURE 38            KEY BUYING CRITERIA, BY END USER    133

FIGURE 39            NORTH AMERICA: GENOMICS MARKET SNAPSHOT          287

FIGURE 40            ASIA PACIFIC: GENOMICS MARKET SNAPSHOT                 338

FIGURE 41            REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET,

2020–2024 (USD BILLION)             427

FIGURE 42            MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOMICS

PRODUCTS MARKET (2024)         428

FIGURE 43            GENOMICS MARKET: BRAND/PRODUCT COMPARISON   430

FIGURE 44            GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024     432

FIGURE 45            GENOMICS MARKET: COMPANY FOOTPRINT                 433

FIGURE 46            GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024               439

FIGURE 47            EV/EBITDA OF KEY VENDORS   441

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                441

FIGURE 49            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             446

FIGURE 50            ILLUMINA, INC.: COMPANY SNAPSHOT (2024)                 458

FIGURE 51            DANAHER CORPORATION: COMPANY SNAPSHOT (2024)             468

FIGURE 52            F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)             475

FIGURE 53            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)             481

FIGURE 54            QIAGEN: COMPANY SNAPSHOT (2024)   489

FIGURE 55            REVVITY: COMPANY SNAPSHOT (2024)  497

FIGURE 56            LABORATORY CORPORATION OF AMERICA HOLDINGS:

COMPANY SNAPSHOT (2024)      503

FIGURE 57            IQVIA INC.: COMPANY SNAPSHOT (2024)                 507

FIGURE 58            CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)             510

FIGURE 59            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             512

FIGURE 60            EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)    516

FIGURE 61            PACBIO: COMPANY SNAPSHOT (2024)    520

FIGURE 62            OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2024)      527

FIGURE 63            TAKARA BIO INC.: COMPANY SNAPSHOT (2024)                 534

FIGURE 64            EPPENDORF SE: COMPANY SNAPSHOT (2024)                 547

FIGURE 65            MERCK KGAA: COMPANY SNAPSHOT (2024)                 550

FIGURE 66            BD: COMPANY SNAPSHOT (2024)              554

FIGURE 67            ABBOTT: COMPANY SNAPSHOT (2024)  559

FIGURE 68            10X GENOMICS: COMPANY SNAPSHOT (2024)                 563

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧